Kamada Remains Focused on Lung Treatment: CEO Tsur

Oct. 23 (Bloomberg) -- David Tsur, chief executive officer at Kamada, talks with Elliott Gotkine about what comes next for the company after a failed trial for an inhaled treatment for AAT. He speaks on “The Pulse.”

Will Immigration Derail Merkel’s Reelection?
21:40 - Bloomberg’s Matt Miller discusses coming elections in Germany and the popularity of Angela Merkel. He speaks with Francine Lacqua on "Bloomberg Surveillance." (Source: Bloomberg)
  • Wood Says EU Borders Will Tighten Post Spain Attack
  • TheCityUK CEO Says Businesses Need More Detail on Brexit
  • Sponge City: Making Berlin Cooler